FCL AHA Lightening Gel HQ

FCL AHA Lightening Gel HQ is a dermatologist-developed pigmentation corrector designed to target stubborn melasma, sun damage and age-related dark spots. This powerful formulation combines Hydroquinone, Glycolic Acid, Alpha Arbutin, Multifruit AHAs, and antioxidants to inhibit excess melanin production while gently exfoliating the skin.

The result? A brighter, clearer and more uniform complexion with reduced dark patches and improved clarity.
The gel-texture is fast-absorbing, non-steroidal and safe for long-term use when used as directed.

Ideal for dull, uneven, pigmented and sun-damaged skin.

Hydroquinone, Glycolic Acid, Alpha Arbutin, Multifruit BSC (Bilberry Extract, Sugar Cane Extract, Orange Extract, Lemon Extract, Sugar Maple Extract), Grapefruit Extract, RonaCare Pristine Bright

FAQs

Q1. What active ingredients are in FCL AHA Lightening Gel HQ and how do they work together?
A1. FCL AHA Lightening Gel HQ combines pharmaceutical-grade Hydroquinone with Glycolic Acid (an Alpha Hydroxy Acid) and natural AHA sources. Hydroquinone is the most potent depigmenting agent in dermatology — it inhibits tyrosinase (the enzyme that converts tyrosine to melanin precursors) more comprehensively than cosmetic brighteners, and at higher concentrations also exerts cytostatic effects on overactive melanocytes that other ingredients cannot replicate. Glycolic Acid works in parallel through a completely different mechanism: it dissolves the protein bonds between dead corneocytes in the outer skin layer, accelerating the physical shedding of melanin-containing surface cells while simultaneously increasing Hydroquinone's penetration to the living epidermal layers below. The result is dual-pathway depigmentation — active melanin suppression from Hydroquinone, accelerated pigmented cell removal from Glycolic Acid — working simultaneously for faster and more comprehensive results than either ingredient could achieve alone.

Q2. Is FCL AHA Lightening Gel HQ a prescription product?
A2. Yes — FCL AHA Lightening Gel HQ should be used under dermatologist supervision. Hydroquinone is a pharmaceutical-grade active with documented risk of exogenous ochronosis (paradoxical bluish-grey discolouration of skin) with prolonged unsupervised use, particularly in darker skin tones (Fitzpatrick types III–VI) which are most common in India. A dermatologist will assess melasma type (epidermal, dermal, or mixed), appropriate treatment cycle length (typically 8–12 weeks followed by a rest period), and suitability — ensuring the significant benefits of Hydroquinone are captured while minimising this risk. Pregnant and breastfeeding women should not use products containing Hydroquinone.

Q3. How quickly does FCL AHA Lightening Gel HQ produce visible improvement in melasma and dark spots?
A3. Initial visible lightening of surface pigmentation typically begins within 3–4 weeks of consistent nightly use, as Glycolic Acid accelerates the shedding of melanin-loaded corneocytes. Deeper melasma — particularly the dermal component that involves pigment deposits below the epidermis — requires 8–12 weeks for significant visible improvement. Results develop faster than cosmetic-only brightening regimens due to Hydroquinone's pharmaceutical potency. After achieving target improvement, a dermatologist-supervised maintenance plan using cosmetic brighteners (Niacinamide, Azelaic Acid) rather than ongoing Hydroquinone reduces relapse risk while avoiding cumulative HQ exposure.

Q4. How does FCL AHA Lightening Gel HQ differ from a cosmetic brightening serum?
A4. Cosmetic brightening serums use ingredients like Niacinamide, Vitamin C, Alpha Arbutin, and Kojic Acid — all effective tyrosinase inhibitors with good safety profiles for self-directed use. FCL AHA Lightening Gel HQ with Hydroquinone operates at a pharmaceutical level that cosmetic serums cannot match: the depth and speed of depigmentation is significantly greater, making it appropriate for moderate-to-severe melasma and stubborn PIH that cosmetic serums have not adequately addressed over 12+ weeks. The tradeoff is that Hydroquinone carries more risk and requires medical oversight; cosmetic serums can be used indefinitely without physician involvement.

Q5. What skincare routine precautions apply when using FCL AHA Lightening Gel HQ?
A5. Apply only to pigmented areas in the evening, after cleansing and allowing the skin to dry completely. Glycolic Acid and Hydroquinone together significantly increase photosensitivity — unprotected UV exposure during treatment will not only counteract results but risk new or worsened pigmentation. Apply SPF50+ sunscreen every morning without exception, reapplying every 2 hours outdoors. Do not combine with Retinoids, additional AHAs, BHAs, or Vitamin C in the same evening routine unless specifically prescribed. Avoid contact with the eye area, nostrils, and lip margins where skin is too thin for this combination.

Country of Origin: India
Mfg/Marketer details: Fixderma India Pvt. Ltd., F-169-170, E.P.I.P Zone, Neemrana, District Alwar, Rajasthan - 301705, India
Shelf Life: 24 months from manufacturing date
Storage: Store in a cool, dry place away from direct sunlight
Safety Information: For external use only. Avoid contact with eyes and mucous membranes. May increase photosensitivity — use sunscreen during the day. Discontinue use if irritation occurs. Keep out of reach of children.